TWD 75.9
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.86 Billion TWD | 42.75% |
2022 | 1.3 Billion TWD | -20.56% |
2021 | 1.64 Billion TWD | -21.82% |
2020 | 2.09 Billion TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.68 Billion TWD | -9.45% |
2024 Q2 | 1.59 Billion TWD | -5.47% |
2023 FY | 1.86 Billion TWD | 42.75% |
2023 Q3 | 2.11 Billion TWD | -8.89% |
2023 Q2 | 2.31 Billion TWD | 115.02% |
2023 Q1 | 1.07 Billion TWD | -17.28% |
2023 Q4 | 1.86 Billion TWD | -11.91% |
2022 Q4 | 1.3 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | 10.46% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -58.37% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | -53.359% |
TTY Biopharm Company Limited | 9.87 Billion TWD | 81.15% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 84.129% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 82.783% |
Center Laboratories, Inc. | 27 Billion TWD | 93.106% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -184.609% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | 27.363% |
InnoPharmax Inc. | 524.19 Million TWD | -255.105% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | 6.598% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | -18.012% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | -2.692% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | 38.712% |
UniPharma Co., Ltd. | 350.07 Million TWD | -431.729% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | 16.097% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | -91.269% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -132.165% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -324.914% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -243.03% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | -32.974% |